Genome Magazine

Progress in the development of immunotherapies, which aim to unleash the immune system against a cancer, has been slower for AML than for other forms of leukemia. ow.ly/28dd50hdnAw

“What’s it going to do to her life? Just because she has the gene doesn’t mean she would ever have symptoms of the disease.” ow.ly/wpo050hdnyT

The problem with ‘trust us’ consumer genetics ow.ly/qO7d50hdnxA

Earlier this year, Apple unveiled its solution for improving electronic health records (EHRs): an iPhone feature that will allow users to automatically download some of their health records from different providers into one central platform. ow.ly/OHrr50hdnyf

Researchers are suggesting we can calibrate the risk of developing diseases involving multiple genes — like coronary artery disease — in ways that are meaningful for individuals. ow.ly/RZGU50hdnwN

“I can’t tell you how hard it is to have such a life-transforming system and have to tell someone else who could benefit from it, ‘We can’t give it to you.’” ow.ly/eR1e50hdnlb

Can genetics identify people with cardiac disease who might benefit the most from exercise? ow.ly/tnpQ50hdnkx

Over the past decade, hundreds of scientists have participated in an NIH program called The Cancer Genome Atlas to gather information on 11,000 tumors that span 33 different types of cancer. ow.ly/hSD050hdnbd

Hair culture is complex, but perhaps even more complex is the way our hair pigments are entangled within our DNA. ow.ly/Cjhp50hdnan

New research offers hope that a therapy for inflammatory bowel disease (IBD) could also reduce the risk of developing Parkinson’s. ow.ly/kXu950hdn9d

A personal risk score may be the next big thing in genetic medicine. But is that a good thing? ow.ly/nZbe50hcGgF

“Clinical trials are ongoing to determine whether inhibiting inflammatory signaling can be used to treat anxiety and depression.” ow.ly/veTB50ha2gj

Genomics is no longer primarily supported by public institutions. Rather, as in other areas of cutting-edge science, the field is fueled by investments made by private philanthropists, venture capitalists, start-ups, and major pharmaceutical companies. ow.ly/VTZX50ha2fx

Does lifestyle genetic testing diminish medical genetics? ow.ly/iOwg50ha2eP

Fitness helps prevent heart disease, even for those with genetic risk factors. ow.ly/rrtY50hbwFy

Acute myeloid leukemia (AML) is both intense and aggressive. #AML is capable of turning deadly in a matter of months, weeks, or even days. But after decades of stagnation, researchers have finally made some progress in treating it. ow.ly/t9SE50ha2el

It’s never too late to join the #DNADay18 celebration! Take a #DNADayselfie, and share it on Facebook and Twitter.

Tell us how YOU are celebrating #DNADay18. Shoot a video or photo of your #DNADay18 activities and share it on Facebook or Twitter.

Join the celebration and be a part of #DNADay18 bit.ly/2okNnAW @DNAday

“As a person who studied the history of science, I can tell you an informed and engaged population is our best chance at having the potential in genetics come to fruition,” says Dana Waring, co-founder of the Personal Genetics Education Project. ow.ly/RrtS50ha1Z4